

# LiverFibrosisDetection (Beta) ü©∫

**Sub-Project of [Deep Learning for Liver and Tumor Volumetry in Preoperative Planning](https://github.com/Oumar199/LiverVolumetry)**  

## Application Preview 

https://github.com/user-attachments/assets/75cb8433-0e42-438a-920c-ceab13f072fd


## Description

LiverFibrosisDetection is an open-source Python package for automatic liver fibrosis detection and clinical analysis based on deep learning. It implements a multi-modal AI pipeline designed for the screening of liver fibrosis. It bridges the gap between raw probability scores and clinical actionability by combining **EfficientNet (CNN)**, **Multi-Layer Perceptron (MLP)**, and **MedGemma 1.5-4B-it (LLM)**.

## üß† System Architecture

The diagnostic workflow is structured into three layers:

1.  **Image Feature Extraction (EfficientNet-B0):** Analyzes ultrasound B-mode images to extract **1,280 visual features** (texture, nodularity, echogenicity).
2.  **Clinical Fusion (MLP):** Integrates **21 clinical variables** (Age, BMI, HBV status, biological scores). On clear images, the model achieves **99% confidence**.
3.  **Narrative Interpretation (MedGemma 1.5-4B-IT):** A Large Language Model acts as a "Medical Assistant" to contextualize the classification output into a structured report.

## ü§ñ LLM Integration (MedGemma 1.5-4B-it)

To overcome the "black box" nature of AI, we integrated **Instructed MedGemma 1.5 (4B parameters)**. The model receives the raw prediction score and clinical data to generate a **SOAP Report** (Subjective, Objective, Assessment, Plan).

### Score Interpretation Logic
The system follows strict medical thresholds defined in the system prompt:
*   **Score ‚â• 60%:** **FIBROSIS SUSPICION** (High sensitivity, triggers mandatory confirmation).
*   **50% - 60%:** **GRAY ZONE** (Indicates uncertainty, requires monitoring).
*   **Score < 50%:** **FAVORABLE PROFILE** (Vigilance remains if clinical risk factors are present).

### Clinical Guardrails
*   **Strict Rules:** The LLM is programmed to never invent symptoms and must always recommend a **FibroScan** or **Biopsy** for scores above 60%.
*   **Screening Tool:** The output explicitly states that the AI is a screening aid, not a definitive diagnosis.

## üìä Performance & Results

The prediction model was validated on a dataset of **114 images** with a strategy prioritizing **Recall** (sensitivity) to minimize missed pathological cases.


| Metric | Value |
| :--- | :--- |
| **Recall (Sensitivity)** | **61%** |
| **Precision** | 27% |
| **F1-Score** | 0.373 |

### Confusion Matrix (Validation Set)


| | Predicted Healthy | Predicted Fibrosis |
| :--- | :---: | :---: |
| **Actual Healthy** | **68** (True Negatives) | **28** (False Positives) |
| **Actual Diseased** | **8** (False Negatives) | **10** (True Positives) |

*Decision Trade-off: The system accepts a higher False Positive rate (31%) to ensure that 61% of diseased cases are captured in a non-invasive screening stage.*

## üìù Example Output Format (SOAP)

The model generates reports structured as follows:
*   **S (Subjective):** Patient history and identified risk factors.
*   **O (Objective):** AI probability score and clinical-imaging concordance.
*   **A (Assessment):** Estimated fibrosis stage (F0-F4) and confidence level.
*   **P (Plan):** Recommended follow-up (FibroScan, lifestyle changes, labs).

### MedGemma 1.5-4b-it's System Prompt

```
You are an expert hepatology AI diagnostic assistant.

Your task is to write a structured clinical report in the SOAP format (Subjective, Objective, Assessment, Plan) IN ENGLISH, based STRICTLY on the provided clinical data and AI imaging results.

AI MODEL CONTEXT:
- Hybrid CNN-MLP model trained on 201 Senegalese patients (29 sick, 172 healthy)
- Performance: F1=0.373, Recall=61%, Precision=27%
- Trade-off: Favors detection (accepts 31% false positives to limit false negatives)
- Inputs: Liver ultrasound + 21 clinical variables
- Limitations: No access to biopsy, FibroScan, MRI, or complete blood work

SCORE INTERPRETATION (STRICTLY FOLLOW THIS):
- 0-40%: Very favorable profile -> Standard annual surveillance
- 41-49%: Favorable profile -> 6-12 month surveillance
- 50-59%: Gray zone -> FibroScan recommended
- 60-74%: Moderate suspicion -> FibroScan + liver blood panel
- 75-100%: High suspicion -> FibroScan + liver biopsy

FIBROSIS STAGE ESTIMATION:
- 0-30% -> Probable F0 (normal parenchyma)
- 31-45% -> Probable F0-F1 (normal to minimal fibrosis)
- 46-55% -> Possible F1-F2 (mild to moderate fibrosis)
- 56-70% -> Possible F2-F3 (moderate to severe fibrosis)
- 71-100% -> Possible F3-F4 (severe fibrosis to cirrhosis)

ABSOLUTE RULES:
1. ‚ùå NEVER say "the image shows" (you do not have direct access to the ultrasound image).
2. ‚ùå NEVER invent biological values that are not provided.
3. ‚ùå NEVER contradict the provided AI score.
4. ‚ùå NEVER state a definitive diagnosis.
5. ‚úÖ ONLY use the provided data.
6. ‚úÖ Use cautious language: "suggests", "compatible with", "probable".
7. ‚úÖ Always mention the AI model's limitations in the Assessment.
8. ‚úÖ Insist on confirmation by reference exams in the Plan.

EXPECTED SOAP FORMAT:
**S (SUBJECTIVE):** Patient profile (age, sex, BMI), identified risk factors, present symptoms.
**O (OBJECTIVE):** AI Score + interpretation, relevant clinical signs.
**A (ASSESSMENT):** Probable stage, confidence level with justification based on AI limits.
**P (PLAN):** Complementary exams, surveillance, lifestyle advice.

‚≠ê CRITICAL GENERATION RULE ‚≠ê
Generate DIRECTLY and ONLY the final report.
IT IS STRICTLY FORBIDDEN to generate a thinking process or draft.
The VERY FIRST WORD of your response MUST be exactly: **S (SUBJECTIVE):
```

---

## üß™ Quick Test (Google Colab)
For a zero-setup experience, you can run the full analysis pipeline in one click (consider moving to t4 Tesla GPU for faster execution and restarting the session after executing the first cell):

[![Open In Colab](https://colab.research.google.com/assets/colab-badge.svg)](https://colab.research.google.com/github/Oumar199/LiverFibrosisDetection/blob/main/liver_fibrosis_detection_analysis.ipynb)


---

## License

MIT License. See [LICENSE](LICENSE).

---

## Maintainers

- **Oumar199** (GitHub: [@Oumar199](https://github.com/Oumar199))
- **CheikhYakhoubMAAS** (Github: [@CheikhYakhoubMAAS](https://github.com/CheikhYakhoubMAAS))
- **MamadouBousso** (Github: [@MamadouBousso](https://github.com/MamadouBousso))
- **ms-dl** (Github: [@ms-sl](https://github.com/ms-dl))
- **Aby1diallo** (Github: [@Aby1diallo](https://github.com/Aby1diallo))

---

## References

- Preceding Released Scientific Papers: [*Early Detection of Liver Fibrosis*](https://link.springer.com/chapter/10.1007/978-3-031-79103-1_1)

---

## Disclaimer

This is not a substitute for professional medical advice. Outputs should be validated with clinical experts before deployment. Do not use real patient data in this repository.

## Citation
```bibtex
@misc{snaimasters2026liverfibrosisdetection,
  title={Liver Fibrosis Detection},
  author={Cheikh Yakhoub MAAS, Mamadou BOUSSO, Oumar KANE, Metou SANGHE, Aby DIALLO},
  howpublished={https://github.com/Oumar199/LiverFibrosisDetection},
  year={2026}
}
```
